- Home
- NKTR vs GTE Comparison
NKTR vs GTE Comparison
Compare NKTR & GTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- GTE
- Stock Information
- Founded
- NKTR 1990
- GTE 2003
- Country
- NKTR United States
- GTE Canada
- Employees
- NKTR N/A
- GTE N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- GTE Oil & Gas Production
- Sector
- NKTR Health Care
- GTE Energy
- Exchange
- NKTR Nasdaq
- GTE Nasdaq
- Market Cap
- NKTR 238.7M
- GTE 253.1M
- IPO Year
- NKTR 1994
- GTE N/A
- Fundamental
- Price
- NKTR $1.32
- GTE $6.74
- Analyst Decision
- NKTR Buy
- GTE Hold
- Analyst Count
- NKTR 4
- GTE 1
- Target Price
- NKTR $2.50
- GTE $10.00
- AVG Volume (30 Days)
- NKTR 988.9K
- GTE 351.9K
- Earning Date
- NKTR 11-05-2024
- GTE 10-29-2024
- Dividend Yield
- NKTR N/A
- GTE N/A
- EPS Growth
- NKTR N/A
- GTE 7.45
- EPS
- NKTR N/A
- GTE 1.56
- Revenue
- NKTR $93,157,000.00
- GTE $658,051,000.00
- Revenue This Year
- NKTR N/A
- GTE $11.16
- Revenue Next Year
- NKTR N/A
- GTE $20.54
- P/E Ratio
- NKTR N/A
- GTE $4.30
- Revenue Growth
- NKTR 6.17
- GTE 3.94
- 52 Week Low
- NKTR $0.41
- GTE $4.72
- 52 Week High
- NKTR $1.93
- GTE $10.40
- Technical
- Relative Strength Index (RSI)
- NKTR 56.07
- GTE 51.63
- Support Level
- NKTR $1.11
- GTE $6.07
- Resistance Level
- NKTR $1.39
- GTE $6.40
- Average True Range (ATR)
- NKTR 0.09
- GTE 0.32
- MACD
- NKTR 0.01
- GTE 0.15
- Stochastic Oscillator
- NKTR 75.00
- GTE 84.16
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About GTE Gran Tierra Energy Inc.
Gran Tierra Energy Inc is an independent energy company. It is engaged in the acquisition, exploration, development, and production of oil and gas properties. The firm produces light crude oil, supplemented with medium crude and natural gas. Gran Tierra holds interests in producing and prospective properties in Colombia and prospective properties in Ecuador. The company derives its revenue from Colombia.